Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Dali Yan
Role of Nab-Paclitaxel in Metastatic Breast Cancer: A Meta-Analysis of Randomized Clinical Trials
Oncotarget
Oncology
Related publications
Quality-Adjusted Survival With Nab -Paclitaxel vs Standard Paclitaxel in Metastatic Breast Cancer: A Q-TWiST Analysis
Clinical Breast Cancer
Cancer Research
Oncology
Nab-Paclitaxel for the Management of Triple-Negative Metastatic Breast Cancer
Anti-Cancer Drugs
Cancer Research
Oncology
Pharmacology
Comparative Effectiveness of Early-Line Nab-Paclitaxel vs. Paclitaxel in Patients With Metastatic Breast Cancer: A US Community-Based Real-World Analysis
Cancer Management and Research
Oncology
Nab-Paclitaxel Monotherapy in Patients With Metastatic Breast Cancer With Visceral Crisis: Evaluation of Efficacy and Tolerability in Clinical Practice
Medical Council
Caveolin-1 Expression Predicts Efficacy of Weekly Nab-Paclitaxel Plus Gemcitabine for Metastatic Breast Cancer in the Phase II Clinical Trial
BMC Cancer
Cancer Research
Oncology
Genetics
Tumor Reduction in Primary and Metastatic Pancreatic Cancer Lesions With Nab-Paclitaxel and Gemcitabine
Pancreas
Internal Medicine
Endocrinology
Hepatology
Metabolism
Diabetes
Network Meta-Analysis of Randomized Clinical Trials: Reporting the Proper Summaries
Clinical Trials
Medicine
Pharmacology
Biased Safety Reporting in Blinded Randomized Clinical Trials: Meta-Analysis of Angiotensin Receptor Blocker Trials
PLoS ONE
Multidisciplinary
A Systematic Review of Gemcitabine and Taxanes Combination Therapy Randomized Trials for Metastatic Breast Cancer
SpringerPlus
Multidisciplinary
